Impact of rapamycin on delayed graft function in kidney transplant recipients: a meta-analysis
Objective To evaluate the effect of rapamycin on DFG (delayed graft function in kidney transplant) recipients through a systematic review and meta-analysis.Methods We searched PubMed, Embase, Cochrane Library, and other databases for studies assessing rapamycin use in kidney transplantation with a f...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Renal Failure |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2025.2515530 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839645785581420544 |
|---|---|
| author | Yan Tang Jiefu Zhu Xiaolan Mao Zhitao Cai |
| author_facet | Yan Tang Jiefu Zhu Xiaolan Mao Zhitao Cai |
| author_sort | Yan Tang |
| collection | DOAJ |
| description | Objective To evaluate the effect of rapamycin on DFG (delayed graft function in kidney transplant) recipients through a systematic review and meta-analysis.Methods We searched PubMed, Embase, Cochrane Library, and other databases for studies assessing rapamycin use in kidney transplantation with a focus on DGF. The search was conducted from the time of database construction to December 2024. Literature search and quality evaluation were conducted by two researchers. Data were analyzed using RevMan 5.3, with odds ratio (OR) for dichotomous outcomes and mean differences (MD) for continuous outcomes. The meta-analysis was performed with Q-I2; fixed model for I2 < 50%; sensitivity analysis for I2 ≥ 50%. p Values < 0.05 were considered statistically significant.Results Nine studies (n = 9,219) were included. Rapamycin was associated with an increased risk of DGF (OR = 1.29, 95% CI: 1.04–1.58), with a prolonged DGF duration (MD = 8.86, 95% CI: 3.84–13.89). No significant differences were found in graft survival (OR = 1.40, 95% CI: 0.72–2.73); patient survival (OR = 1.89, 95% CI: 0.84–4.26), or rejection incidence (OR = 1.22, 95% CI: 0.78–1.90).Conclusions Rapamycin significantly increases the risk and duration of DGF after kidney transplantation. However, it does not appear to affect long-term outcomes such as graft survival or rejection rates. These findings suggest that rapamycin should be used cautiously in transplant recipients at risk for DGF, and further studies are needed to optimize immunosuppressive strategies for this population. |
| format | Article |
| id | doaj-art-db87fce15e43450eabc2c07bc021b882 |
| institution | Matheson Library |
| issn | 0886-022X 1525-6049 |
| language | English |
| publishDate | 2025-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Renal Failure |
| spelling | doaj-art-db87fce15e43450eabc2c07bc021b8822025-07-01T09:48:14ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492025-12-0147110.1080/0886022X.2025.2515530Impact of rapamycin on delayed graft function in kidney transplant recipients: a meta-analysisYan Tang0Jiefu Zhu1Xiaolan Mao2Zhitao Cai3The Department of Organ Transplantation, Renmin Hospital of Wuhan University, Wuhan, ChinaThe Department of Organ Transplantation, Renmin Hospital of Wuhan University, Wuhan, ChinaThe Nursing Department, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, ChinaThe Department of Organ Transplantation, Renmin Hospital of Wuhan University, Wuhan, ChinaObjective To evaluate the effect of rapamycin on DFG (delayed graft function in kidney transplant) recipients through a systematic review and meta-analysis.Methods We searched PubMed, Embase, Cochrane Library, and other databases for studies assessing rapamycin use in kidney transplantation with a focus on DGF. The search was conducted from the time of database construction to December 2024. Literature search and quality evaluation were conducted by two researchers. Data were analyzed using RevMan 5.3, with odds ratio (OR) for dichotomous outcomes and mean differences (MD) for continuous outcomes. The meta-analysis was performed with Q-I2; fixed model for I2 < 50%; sensitivity analysis for I2 ≥ 50%. p Values < 0.05 were considered statistically significant.Results Nine studies (n = 9,219) were included. Rapamycin was associated with an increased risk of DGF (OR = 1.29, 95% CI: 1.04–1.58), with a prolonged DGF duration (MD = 8.86, 95% CI: 3.84–13.89). No significant differences were found in graft survival (OR = 1.40, 95% CI: 0.72–2.73); patient survival (OR = 1.89, 95% CI: 0.84–4.26), or rejection incidence (OR = 1.22, 95% CI: 0.78–1.90).Conclusions Rapamycin significantly increases the risk and duration of DGF after kidney transplantation. However, it does not appear to affect long-term outcomes such as graft survival or rejection rates. These findings suggest that rapamycin should be used cautiously in transplant recipients at risk for DGF, and further studies are needed to optimize immunosuppressive strategies for this population.https://www.tandfonline.com/doi/10.1080/0886022X.2025.2515530Rapamycindelayed graft functionkidney transplantationmeta-analysisimmunosuppression |
| spellingShingle | Yan Tang Jiefu Zhu Xiaolan Mao Zhitao Cai Impact of rapamycin on delayed graft function in kidney transplant recipients: a meta-analysis Renal Failure Rapamycin delayed graft function kidney transplantation meta-analysis immunosuppression |
| title | Impact of rapamycin on delayed graft function in kidney transplant recipients: a meta-analysis |
| title_full | Impact of rapamycin on delayed graft function in kidney transplant recipients: a meta-analysis |
| title_fullStr | Impact of rapamycin on delayed graft function in kidney transplant recipients: a meta-analysis |
| title_full_unstemmed | Impact of rapamycin on delayed graft function in kidney transplant recipients: a meta-analysis |
| title_short | Impact of rapamycin on delayed graft function in kidney transplant recipients: a meta-analysis |
| title_sort | impact of rapamycin on delayed graft function in kidney transplant recipients a meta analysis |
| topic | Rapamycin delayed graft function kidney transplantation meta-analysis immunosuppression |
| url | https://www.tandfonline.com/doi/10.1080/0886022X.2025.2515530 |
| work_keys_str_mv | AT yantang impactofrapamycinondelayedgraftfunctioninkidneytransplantrecipientsametaanalysis AT jiefuzhu impactofrapamycinondelayedgraftfunctioninkidneytransplantrecipientsametaanalysis AT xiaolanmao impactofrapamycinondelayedgraftfunctioninkidneytransplantrecipientsametaanalysis AT zhitaocai impactofrapamycinondelayedgraftfunctioninkidneytransplantrecipientsametaanalysis |